Market Snapshot

BSE Sensex: 74563.92 -1.93%
BSE 500: 33516.43 -2.29%
BSE 200: 10577.12 -2.22%
BSE 100: 24324.92 -2.15%
BSE BANKEX: 60462.88 -2.44%
BSE IT: 28151.52 -1.73%
Nifty 50: 23151.1 -2.06%
Nifty 500: 21391.2 -2.31%
Nifty 200: 13018.25 -2.25%
Nifty 100: 23849.25 -2.16%
Nifty Midcap 100: 54761.1 -2.65%
Nifty Small 100: 15895.25 -2.51%
Nifty IT: 29071.25 -1.72%
Nifty PSU Bank: 8516.55 -3.72%

News:

GE Power India CFO Aashish Gha...
Meta Infotech secures renewal ...
Prostarm Info bags Rs 7-cr sol...
3i Infotech bags cloud service...
Dilip Buildcon bags Rs 160-cr ...

Jagsonpal Pharmaceuticals Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

13 Mar 2026 | 04:14 PM

182.96

-6.65 (-3.51%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-10.73%

Return (1Y)

Underperformed Nifty 50 by 14.1%
More Volatile

2.74%

Standard Deviation (1Y)

Higher than Nifty 50 by 1.95%
Inconsistent Performer

2/12

Months

underperformed Nifty 50
AxisDirect View

No View

52 Week High-Low

302

155

News & Announcements

Board of Jagsonpal Pharmaceuticals approves shares buyback of Rs 40 cr
2 days ago

Board of Jagsonpal Pharmaceuticals approves shares buyback of Rs 40 cr

12 - Mar - 2026 12:00 | 2 days ago

The Board of Jagsonpal Pharmaceuticals at its meeting held on 12 March 2026 approved a proposal to buyback up to 16,00,000 fully paid-up equity shares of the company at a price of Rs 250 per equity shares (a premium of through Tender Offer method, subject to shareholders approval. This represents 2.4% of the total equity shares of the Company and 7.3% of the non-promoter shareholding of the company. The proposed buyback will be undertaken for an aggregate amount not exceeding Rs 40 crore, representing ~18.4% of the company's total paid-up equity share capital and free reserves based on the latest audited financial statements as of 31 March 2025.
Powered by Capital Market - Live News
Jagsonpal Pharmaceutical surges as board approves Rs 40-cr buyback
2 days ago

Jagsonpal Pharmaceutical surges as board approves Rs 40-cr buyback

12 - Mar - 2026 12:00 | 2 days ago

The board approved the buyback of upto Rs 16 lakh equity shares, representing 2.39% of total outstanding equity shares. The buyback will be carried out at a price of Rs 250 per share, aggregating to a maximum outlay of Rs 40 crore.
The buyback price represents a premium of 39.74% over the previous day?s closing price of Rs 178.90 on the BSE.
The company?s promoter and promoter group shareholding stood at 67.2% prior to the buyback and is expected to increase to 68.9% post buyback.
Jagsonpal Pharmaceuticals has portfolio of drugs focusing on gynaecology, orthopaedics, dermatology and child-care segments.
The company?s standalone net profit fell 8.4% to Rs 12.49 crore on 1.5% fall in net sales to Rs 72.95 crore in Q3 FY26 compared with Q3 FY25.
Powered by Capital Market - Live News
Jagsonpal Pharma sizzles as board to mull buyback proposal
4 days ago

Jagsonpal Pharma sizzles as board to mull buyback proposal

10 - Mar - 2026 12:00 | 4 days ago

As on 31st December 2025, the company?s promoter shareholding stood at 67.39%.
Jagsonpal Pharmaceuticals has portfolio of drugs focusing on gynaecology, orthopaedics, dermatology and child-care segments.
The company?s standalone net profit fell 8.4% to Rs 12.49 crore on 1.5% fall in net sales to Rs 72.95 crore in Q3 FY26 compared with Q3 FY25.
Powered by Capital Market - Live News
Jagsonpal Pharmaceuticals announces board meeting date
4 days ago

Jagsonpal Pharmaceuticals announces board meeting date

10 - Mar - 2026 12:00 | 4 days ago

Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 March 2026.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

MF shareholding in Jagsonpal Pharmaceuticals Ltd has increased by 9.09% since past 3 Months

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

General Notifications

My Notifications

Research Notifications

Jagsonpal Pharmaceuticals Ltd Share Price – NSE / BSE Pharmaceuticals, Small Cap

182.96 -6.65 (-3.51%)

News & Announcements

Price vs Volume

Stock Trivia

Jagsonpal Pharmaceuticals Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

182.96

-6.65 (-3.51%)